Duodenal Switch and SADI-S: The Strongest Operations
The strongest weight-loss operations send food past most of the intestine, and the body keeps less of everything, zinc included.

If you want a body to hold on to fewer calories, there are basically two plans. You can make the stomach smaller so less food goes in, which is what the sleeve does, or you can let the food in and then send it past a long stretch of intestine so less of it is kept on the way through. The duodenal switch does both, and its newer cousin SADI-S (single anastomosis duodeno-ileal bypass, which is a lot of syllables for one connection) does roughly the same thing through a single join, as the name says.
On the evidence these are the strongest weight-loss operations around. A review of very long-term outcomes found that at 10 years, weighted mean total weight loss ranged from 24.4% for sleeve gastrectomy to approximately 40% for BPD-DS, and that SADI-S data at 10 years showed 80% excess weight loss “with acceptable complication rates.” The price is malabsorption. The body absorbs less, and it does not get to choose what it absorbs less of. Who should actually get these operations is much less settled than how well they work.
What a duodenal switch does, in the dumb version
Here is the mechanism in the plainest words I can manage. You eat food. The food travels down a long tube that pulls useful things out of it. If the food skips most of the tube, less gets pulled out. The official name for this is malabsorption.
The tube works like a toll road with a long row of booths, each collecting a little of what passes. The operation builds an exit ramp that sends traffic around most of the booths and rejoins the road near the end. Same cars, fewer tolls. (Nobody at the Department of Transportation would approve this, which is one advantage of medicine.)
The dumb version also explains why weight stays off. A review in Frontiers on endoscopic fixes for regain said BPD/DS is not associated with high rates of weight recurrence because it “significantly induces malabsorption, making it physiologically more complex to regain weight.” That is a careful way of saying the booths are still closed. A separate study of what happens after the conditions come back found RYGB and duodenal switch were associated with lower risks of diabetes and high-cholesterol recurrence compared with sleeve gastrectomy.
Now a hypothetical, clearly made up, to push the dumb version until it breaks. If closing some booths works, close all of them. The patient eats a full dinner, keeps none of it, and becomes a very expensive pipe. This is not a real operation. The reason it is not real is the rest of this article.
How much weight the strongest operations take off
The numbers are large in a way that is a little weird to read next to the sleeve. A network meta-analysis comparing bariatric operations found SADI-S was the most effective for reducing BMI, by a mean difference of 18.06 points (confidence interval 10.81 to 25.31), with heterogeneity of 98.5%. (That last number is the statistician’s way of saying the studies disagreed with each other enormously while all agreeing the answer was big.) The same analysis found the bypass-plus-diversion version (BPD-RYGB) was most effective for absolute weight, at about 41.48 kilograms, and for fat mass, at 31.11 kilograms, with heterogeneity of 0%. For once, everyone agreed.
A different network meta-analysis ranked procedures by how well they improved obesity-related conditions, and SADI ranked highest for diabetes, with a P-score of 0.932. I write about finance, where a ranking with three decimal places usually means someone is about to sell you a fund. Here it is just a meta-analysis. I feel like that is progress.
The sophisticated version: bile acids, hormones and lunch
The dumb version says food skips the booths. The sophisticated version says something more interesting is going on, and it has a study to prove it. A prospective case-control study compared 37 gastric bypass patients, 31 SADI-S patients and 19 non-obese controls. Its title promises “Nutrient-Stimulated Hormone Responses,” which sounds like a channel you would scroll past quickly in a hotel. It is in fact about what happens to people’s blood after lunch.
The first finding is a bit awkward for the dumb version. A standard bile acid test found no bile acid malabsorption in the SADI-S patients at all. So the malabsorptive operation is not malabsorbing that, at least. Instead, fasting levels of certain conjugated bile acids were higher after SADI-S than after bypass. A gut hormone called FGF19 peaked at 90 minutes after a mixed meal in both groups, and its rise tracked the rise in those bile acids, particularly after SADI-S.
Then the hunger hormone ghrelin went up after bypass but was suppressed after SADI-S. GLP-1 responses were “supraphysiological” after both, meaning the operated gut was producing more of the hormone that the site’s other favorite treatment is named after than a normal gut does. In an exploratory analysis, the bigger the rise in conjugated bile acids, the less weight people regained from their lowest point at 5 years.
There is a related finding from gastric bypass, which also routes food past the duodenum. Patients who regained 100% or more of their surgically lost weight still kept their diabetes in remission in roughly 60% of cases, which the authors read as a weight-independent benefit of the duodenal bypass. So the sophisticated version is: hormones, bile acids, signaling, appetite, etc. It is not just closed booths.
And where does the sophisticated version end up? In that same study, weight loss was greater with SADI-S than bypass at 1 year but not significantly different at 3 and 5 years. The hormones were doing their elaborate thing, and the result was a body that kept less. Which is what the dumb version said.
What malabsorption costs
The bill comes from the same mechanism. The bile acid study reported that “despite routine supplementation, total protein, zinc, copper, and vitamin A/RBP and vitamin E/cholesterol ratios decreased after both RYGB and SADI-S.” The booths that were collecting calories were also collecting zinc. The exit ramp does not check what kind of car you are.
The consult, presumably, goes something like: “Good news, this is the strongest operation we do. Here is your supplement list. We will be checking your copper.” That is a weird sentence to hear in one breath, but a normal one in this field.
On bones, a long-term study found elevated estimated fracture risk after sleeve, bypass and one-anastomosis bypass. It did not include the duodenal switch or SADI-S, so for the strongest operations that question is not settled by these facts. Which is not reassuring, I suppose, but it is honest.
Who these operations are for, as far as anyone has settled it
Partly, they are for people whose first operation was the sleeve. Sleeve gastrectomy is the most performed bariatric procedure worldwide, and in a 10-year multicenter study from Poland called BARI-10-POL, 24.3% of sleeve patients needed a revisional procedure. That is a lot of people looking for a second plan. (Being the most popular first plan has this side effect.)
A meta-analysis of SADI versus one-anastomosis gastric bypass as the second operation found 4 eligible articles with 309 patients total. At 1 year SADI produced more weight loss on both measures. At 2 years excess weight loss no longer differed, though total weight loss stayed higher with SADI. (This is the sports-trade problem: everyone looks like a genius after one season.) Biliary reflux was more common after the one-anastomosis bypass, and seven of its patients developed ulcers against none after SADI, though that gap missed statistical significance with a P value of 0.07. Close, not quite. That’s fine.
For first-time patients, the head-to-head evidence mostly hasn’t arrived. The BYPSADIS randomized trial “will enroll” 450 patients aged 18 to 60 with BMI of 40 to 50 across six hospitals, split evenly between SADI-S and gastric bypass. Another ongoing trial, SADISLEEVE, includes first and revisional operations with no BMI limits and varying limb lengths. So the question of who these are for is, right now, a protocol or whatever. Why it has taken this long for operations ranked first on several measures to get a big randomized trial against the standard is a dumb but real question that the facts here don’t answer.
Same place, longer road
The dumb version of the duodenal switch fits on a napkin: send the food around most of the toll booths, collect fewer tolls. The sophisticated version takes a mixed-meal test, a 90-minute hormone peak, three conjugated bile acids and a suppressed hunger signal to explain itself. Both versions predict lots of weight lost, diabetes that stays away more often, and zinc and protein that go missing alongside the calories.
The exit ramp is fancier than it looked. It is still an exit ramp.
Sources
- Frontiers | Endoscopic Management of Weight Recurrence Following Bariatric Surgery
- Beyond Initial Resolution: Predictors of Recurrence of Obesity-related Medical Conditions after Metabolic and Bariatric Surgery
- Comparative effectiveness of metabolic and bariatric surgeries: a network meta-analysis
- Laparoscopic Single Anastomosis Duodeno-Ileal Bypass Versus One Anastomosis Gastric Bypass as Revisional Procedures after Sleeve Gastrectomy: Meta-analysis and Systematic Review
- Changes in Bile Acid Metabolism and Nutrient-Stimulated Hormone Responses After Malabsorptive Metabolic Surgery: RYGB Versus SADI-S
- Gastric Bypass Improves Long-Term Diabetes Remission, Even After Weight Recurrence | ACS
- Continued Diabetes Remission Despite Weight Recurrence: Gastric Bypass Long-Term Metabolic Benefit.
- Improvement of Obesity-Related Comorbidities After Bariatric Procedures: A Network Meta-Analysis of Endoscopic Versus Surgical Interventions
- A Comprehensive Review of Sleeve Gastrectomy, Roux-en-Y Gastric Bypass, One-Anastomosis Gastric Bypass, Duodenal Switch, and SADI-S: Very Long-Term Outcomes at 10 Years and Beyond
- A randomized open-label multicentre clinical trial comparing single-anastomosis duodenal switch (SADI-S) versus Roux-en-Y gastric bypass for the treatment of severe obesity: BYPSADIS study protocol
- Seven-Year Comparative Outcomes of One Anastomosis Gastric Bypass and Roux-en-Y Gastric Bypass for Weight Recurrence Regain Post Sleeve Gastrectomy
- Changes in bone metabolism and densitometry after metabolic/bariatric surgery: a comparison of pre- and postoperative results in a prospective long-term study
- Long-term outcomes of metabolic bariatric surgery: a 10-Year multicenter retrospective study in Poland (BARI-10-POL)
Bariatric Alt explains published research. It is not medical advice, and it never recommends a surgeon, a clinic, a dose or a product. Talk to a clinician about which option fits you.